Search

Search Results

• Pharmacoeconomic Analysis of CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemias

  Irina Vladimirovna Gribkova, A.A. Zavyalov

  205-212

  01.04.2022

• Efficacy and Safety of Midostaurin Combined with Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation

  Sergei Nikolaevich Bondarenko, A.G. Smirnova, B.I. Ayubova, E.V. Karyagina, O.S. Uspenskaya, Yu.S. Neredko, A.P. Kochergina, I.A. Samorodova, E.A. Pashneva, Yu.S. Chernykh, Yu.A. Dunaev, N.B. Esef’eva, R.K. Il’yasov, T.I. Brazhkina, I.A. Novokreshchenova, Z.K. Simavonyan, E.I. Kuzub, V.I. Bakhtina, T.I. Olkhovich, M.V. Burundukova, E.V. Babenko, Yu.D. Oleinikova, I.M. Barkhatov, T.L. Gindina, I.S. Moiseev, A.D. Kulagin

  167-175

  01.04.2022

• A Rationale for a New Operational Integrated Quality and Efficiency Index for Assessing the Performance of Hematological Services in Constituent Entities of the Russian Federation

  Elena Nikolaevna Parovichnikova, T.Ts. Garmaeva, O.V. Lazareva, K.A. Lukina, Yu.A. Chabaeva, S.M. Kulikov, V.V. Troitskaya, T.V. Gaponova, L.I. Menshikova, V.G. Savchenko

  1-15

  01.01.2022

• Russian Prospective Non-Randomized Clinical Study on Dose Reduction of Tyrosine Kinase Inhibitors with Subsequent Complete Therapy Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response (READIT-2020): Background, Aim, Mai

  A.G. Turkina, Margarita Anatolevna Gurianova, E.Yu. Chelysheva, O.A. Shukhov

  54-61

  01.01.2022

• The Role of BAALC-Expressing Leukemia Precursor Cells in the Pathogenesis of Myelodysplastic Syndromes

  Nikolai Nikolaevich Mamaev, M.V. Latypova, A.I. Shakirova, T.L. Gindina, M.M. Kanunnikov, N.Yu. Tsvetkov, I.M. Barkhatov, S.N. Bondarenko, M.D. Vladovskaya, E.V. Morozova

  62-68

  01.01.2022

• Biological Mechanisms of Sustaining Deep Molecular Response in Chronic Myeloid Leukemia Upon Withdrawal of Tyrosine Kinase Inhibitors

  Ekaterina Yurevna Chelysheva, M.A. Guryanova, A.G. Turkina

  427-435

  01.10.2021

• Prediction of Treatment Efficacy in Relapsed Chronic Lymphocytic Leukemia

  Olga Borisovna Kalashnikova, I.S. Moiseev, T.L. Gindina, E.A. Izmailova, M.O. Ivanova, E.V. Kondakova, N.B. Mikhailova, A.D. Kulagin

  466-476

  01.10.2021

• Ibrutinib as First-Line Therapy in High-Risk Chronic Lymphocytic Leukemia: Case Reports

  Nadezhda Viktorovna Kurkina, E.A. Repina

  488-495

  01.10.2021

• Technical Aspects of Minimal Residual Disease Detection by Multicolor Flow Cytometry in Acute Myeloid Leukemia Patients

  I.V. Galtseva, Yuliya Olegovna Davydova, N.M. Kapranov, K.A. Nikiforova, E.N. Parovichnikova

  503-512

  01.10.2021

• Acute Myeloid Leukemia Patient-Derived Xenograft Models Generated with the Use of Immunodeficient NSG-SGM3 Mice

  Ekaterina Viktorovna Baidyuk, E.V. Belotserkovskaya, L.L. Girshova, V.A. Golotin, K.A. Levchuk, M.L. Vasyutina, Ya.A. Portnaya, E.V. Shchelina, O.G. Bredneva, A.V. Petukhov, A.Yu. Zaritskey, O.N. Demidov

  414-425

  01.10.2021

• Efficacy, Safety, and Tolerance of Gemtuzumab Ozogamicin Combined with FLAG/FLAG-Ida or Azacitidine in Relapsed/Refractory Acute Myeloblastic Leukemia

  Irina Garmaevna Budaeva, D.V. Zaitsev, A.A. Shatilova, E.N. Tochenaya, A.V. Petrov, R.I. Vabishchevich, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, S.V. Efremova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  299-307

  01.07.2021

• Treatment of Mastocytosis: A Literature Review

  Karina Maksimovna Chernavina, A.S. Orlova, E.A. Nikitin

  361-369

  01.07.2021

• Use of Blinatumomab in Acute Lymphoblastic Leukemia in Municipal Healthcare: A Case Report

  Vasilii Anatolevich Shuvaev, O.V. Ushakova, E.I. Mullo, T.V. Tolstykh, N.Z. Triputen

  198-203

  01.04.2021

• CAR-Т Cells for the Treatment of Chronic Lymphocytic Leukemia: Literature Review

  Irina Vladimirovna Gribkova, A.A. Zav’yalov

  225-230

  01.04.2021

• Hemostasis Disorders in Patients with De Novo Acute Leukemias

  O.A. Polevodova, Gennadii Martinovich Galstyan, V.V. Troitskaya, EB Orel, M.Yu. Drokov, E.N. Parovichnikova

  231-238

  01.04.2021

• Mastocytosis in Adults: A Retrospective Analysis of the Clinical Course and Treatment of 58 Patients

  Vsevolod Gennadevich Potapenko, V.V. Baikov, I.E. Belousova, E.A. Belyakova, M.V. Barabanshchikova, D.V. Zaslavsky, I.S. Zyuzgin, A.V. Klimovich, Yu.A. Krivolapov, T.G. Kulibaba, E.V. Lisukova, E.E. Leenman, L.A. Mazurok, A.M. Maksimova, E.V. Morozova, A.S. Nizamutdinova, K.A. Skoryukova, E.A. Ukrainchenko, N.V. Medvedeva

  158-166

  01.04.2021

• Acute Myeloid Leukemia as Second Tumor in a Patient with Burkitt’s Lymphoma: Literature Review and a Case Report

  Timur Teimurazovich Valiev, T.Yu. Pavlova, A.M. Kovrigina, I.N. Serebryakova

  167-172

  01.04.2021

• Chronic Lymphocytic Leukemia in Blood Relatives: Two Case Reports of Male Siblings

  Nadezhda Viktorovna Kurkina, E.A. Repina

  69-72

  01.01.2021

• Factors for Sustaining Molecular Remission after Discontinuation of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia: Results of Non-Randomized Prospective Clinical Trial

  Oleg Aleksandrovich Shukhov, A.N. Petrova, E.Yu. Chelysheva, A.V. Bykova, I.S. Nemchenko, A.G. Turkina

  1-12

  01.01.2021

• Opportunities of Chronic Myeloid Leukemia Treatment with Reduced Doses of Tyrosine Kinase Inhibitors

  Margarita Anatolevna Guryanova, E.Yu. Chelysheva, A.G. Turkina

  118-128

  01.01.2021

• EVI1-Positive Leukemias and Myelodysplastic Syndromes: Theoretical and Clinical Aspects (Literature Review)

  Nikolai Nikolaevich Mamaev, A.I. Shakirova, E.V. Morozova, T.L. Gindina

  103-117

  01.01.2021

• CAR-T Technology and New Opportunities for Tumor Treatment

  Vera Yurevna Pavlova, E.S. Livadnyi

  149-156

  01.01.2021

• Identification of Mutations in IDH1/2, DNMT3A, ASXL1 Genes of Genome Epigenetic Regulation and Their Co-Occurrence with FLT3, NPM1, RUNX1 Mutations in Acute Myeloid Leukemia

  Ekaterina Vasilevna Belotserkovskaya, E.K. Zaikova, A.V. Petukhov, O.N. Demidov, K.A. Levchuk, I.G. Budaeva, D.V. Zaitsev, Yu.D. Rogovaya, A.A. Shatilova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, A.Yu. Zaritskey, L.L. Girshova

  13-21

  01.01.2021

• CAR T-Cell Therapy with NKG2D Chimeric Antigen Receptor in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

  Kseniya Aleksandrovna Levchuk, E.V. Belotserkovskaya, D.Yu. Pozdnyakov, L.L. Girshova, A.Yu. Zaritskey, A.V. Petukhov

  138-148

  01.01.2021

• New Technology Capabilities of Direct Antiglobulin Test

  Elena Aleksandrovna Poponina, E.V. Butina, A.V. Iovdii, O.D. Maksimov, G.A. Zaitseva, I.V. Paramonov

  426-429

  01.10.2020

• Pattern of Immunocompetent Peripheral Blood Cell Subpopulations in B-Cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  E.G. Kuzmina, T.Yu. Mushkarina, T.V. Konstantinova, Svetlana Valer’evna Zatsarenko, S.V. Shakhtarina, A.Yu. Terekhova, N.A. Falaleeva, L.Yu. Grivtsova

  395-405

  01.10.2020

• Molecular Diagnosis of FLT3 Mutations in Acute Myeloid Leukemia Patients

  E.K. Zaikova, Ekaterina Vasil’evna Belotserkovskaya, D.V. Zaytsev, A.V. Petukhov, O.A. Fedorova, D.V. Motorin, V.V. Ivanov, A.Yu. Zaritskey, L.L. Girshova

  150-160

  01.04.2020

• Chronic Myeloid Leukemia: Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Tyrosine Kinase Inhibitors

  Elena Vladislavovna Morozova, Yu.Yu. Vlasova, M.V. Barabanshchikova, N.N. Mamaev, I.M. Barkhatov, A.L. Alyanskii, E.I. Darskaya, M.V. Vladovskaya, S.N. Bondarenko, I.S. Moiseev, B.V. Afanasyev

  193-198

  01.04.2020

• Diagnosis and Treatment of Clonal Myeloproliferative Neoplasms with Eosinophilia

  Irina Semenovna Nemchenko, N.N. Tsyba, A.G. Turkina, E.Yu. Chelysheva, O.A. Shukhov, A.M. Kovrigina, T.N. Obukhova

  161-169

  01.04.2020

• Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome

  Nikolai Yur’evich Tsvetkov, E.V. Morozova, I.M. Barkhatov, I.S. Moiseev, M.V. Barabanshchikova, A.V. Tishkov, D.S. Bug, N.V. Petukhova, E.A. Izmailova, S.N. Bondarenko, B.V. Afanasyev

  170-175

  01.04.2020

• Materials of the II Conference “Current Issues of Diagnosis and Treatment of Ph-Negative and Ph-Positive Myeloproliferative Neoplasms” (March 15–16, 2019; National Research Center for Hematology, Moscow)

  A.L. Melikyan, A.G. Turkina, Irina Nikolaevna Subortseva, E.Yu. Chelysheva, A.M. Kovrigina, V.A. Shuvaev, V.V. Baikov, O.Yu. Vinogradova, S.M. Kulikov, A.N. Petrova, A.V. Bykova, A.-P.A. Poshivai, Yu.Yu. Vlasova, M.M. Chukavina, O.D. Serdyuk, K.V. Naumova, N.T. Siordiya, N.S. Lazorko, R.V. Grozov, E.I. Mullo, A.S. Maksimova, O.M. Senderova, O.V. Kanya, M.S. Fominykh, D.I. Shikhbabaeva, E.A. Belyakova, I.S. Martynkevich, L.B. Polushkina, M.N. Zenina, E.V. Efremova, V.I. Rugal, L.P. Papayan, N.E. Korsakova, O.Yu. Matvienko, E.B. Syrtseva, S.V. Gappoev, M.V. Barabanshchikova, M.O. Ivanova, K.D. Kaplanov, E.S. Rogova, K.B. Trizna, A.S. Zhevnyak, O.E. Ochirova, A.A. Shakhaeva, A.S. Lyamkina, I.P. Mikhno, Yu.B. Chernykh, T.V. Chudanova, I.N. Kontievskii, N.N. Glonina, M.V. Burundukova

  199-230

  01.04.2020

• Crucial Role of BAALC-Expressing Progenitor Cells in Emergence and Development of Post-Transplantation Relapses in Patients with Acute Myeloid Leukemia

  Nikolai Nikolaevich Mamaev, A.I. Shakirova, I.M. Barkhatov, Ya.V. Gudozhnikova, T.L. Gindina, O.V. Paina, L.S. Zubarovskaya, B.V. Afanas’ev

  75-88

  01.01.2020

• Gemtuzumab Ozogamicin in the Treatment of Critical Patients with Refractory Acute Myeloid Leukemia (3 Case Reports)

  Daniil Vladislavovich Zaitsev, L.L. Girshova, V.V. Ivanov, I.G. Budaeva, D.V. Motorin, R.Sh. Badaev, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, K.A. Zagorodnikova, N.A. Zhukova, S.V. Efremova, T.V. Chitanava, Yu.A. Alekseeva, A.Y. Zaritskey

  67-74

  01.01.2020

• Comparative Analysis of Cardiovascular Disorders in Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitor Therapy

  L.M. Makeeva, E.I. Emelina, A.V. Bykova, Gennadii Efimovich Gendlin, G.A. Gusarova, I.G. Nikitin, E.Yu. Chelysheva, O.Yu. Vinogradova, I.E. Lazarev, E.G. Arshanskaya, A.G. Turkina

  104-111

  01.01.2020

• Heme Oxygenase-1/Ferritin in Protection of Leukemia Cells from Oxidative Stress Induced by Catalytic System “Teraphtal + Ascorbic Acid”

  Tat’yana Aleksandrovna Sidorova, O.O. Ryabaya, A.A. Prokof’eva, D.A. Khochenkov

  416-427

  01.10.2019

• Infections in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib: Incidence and Predisposing Factors

  E.A. Dmitrieva, Evgenii Aleksandrovich Nikitin, E.E. Markova, N.Yu. Dmitrieva, V.V. Ptushkin

  438-448

  01.10.2019

• Antithrombotic Therapy in Patients with Malignant Lymphoproliferative Disorders Treated with Ibrutinib

  Elena Ivanovna Emelina, G.E. Gendlin, I.G. Nikitin

  449-460

  01.10.2019

• A Case of Hairy Cell Leukemia Diagnosed Simultaneously with Lymphoplasmacytic Lymphoma by Anti-CD Antibody Microarray Method

  Alina Nikolaevna Khvastunova, L.S. Al-Radi, O.S. Fedyanina, S.A. Lugovskaya, S.A. Kuznetsova

  243-246

  01.07.2019

• The Use of Ibrutinib in Refractory Chronic Lymphocytic Leukemia and in High-Risk Patients

  Nadezhda Viktorovna Kurkina, E.A. Repina, N.N. Mashnina

  278-281

  01.07.2019

• Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

  Irina Garmaevna Budaeva, E.G. Ovsyannikova, E.N. Goryunova, O.V. Kulemina, D.V. Zaitsev, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  289-296

  01.07.2019